Angiogenin activates the astrocytic Nrf2/antioxidant-response element pathway and thereby protects murine neurons from oxidative stress.
Trish T HoangDelinda A JohnsonRonald T RainesJeffrey A JohnsonPublished in: The Journal of biological chemistry (2019)
The angiogenin (ANG) gene is mutated frequently in individuals with amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease characterized by the progressive loss of motor neurons. Delivering human ANG to mice that display ALS-like symptoms extends their lifespan and improves motor function. ANG is a secretory vertebrate RNase that enters neuronal cells and cleaves a subset of tRNAs, leading to the inhibition of translation initiation and the assembly of stress granules. Here, using murine neuronal and astrocytic cell lines, we find that ANG triggers the activation of the Nrf2 (nuclear factor erythroid 2-related factor 2) pathway, which provides a critical cellular defense against oxidative stress. This activation, which occurred in astrocytes but not in neurons, promoted the survival of proximal neurons that had oxidative injury. These findings extend the role of ANG as a neuroprotective agent and underscore its potential utility in ALS management.
Keyphrases
- amyotrophic lateral sclerosis
- oxidative stress
- angiotensin ii
- induced apoptosis
- nuclear factor
- spinal cord
- dna damage
- ischemia reperfusion injury
- diabetic rats
- toll like receptor
- cerebral ischemia
- endothelial cells
- multiple sclerosis
- subarachnoid hemorrhage
- spinal cord injury
- metabolic syndrome
- signaling pathway
- copy number
- gene expression
- type diabetes
- adipose tissue
- dna methylation
- transcription factor
- genome wide
- skeletal muscle
- brain injury
- drosophila melanogaster